Zingoni A, Soto H, Hedrick J A, Stoppacciaro A, Storlazzi C T, Sinigaglia F, D'Ambrosio D, O'Garra A, Robinson D, Rocchi M, Santoni A, Zlotnik A, Napolitano M
Laboratory of Pathophysiology, Regina Elena Cancer Institute, Rome, Italy.
J Immunol. 1998 Jul 15;161(2):547-51.
In this paper we report on the cloning and characterization of mouse CCR8. Like its human homologue, it is predominantly expressed in the thymus. In the periphery, murine CCR8 mRNA was found most abundantly expressed in activated Th2-polarized cells and in NK1.1+ CD4+ T cells. Human CCR8 is also preferentially expressed in human Th2-polarized cells and clones. This pattern of expression suggests that CCR8 is part of a Th2-specific gene expression program. The CCR8 ligands I-309 and its mouse homologue T cell activation gene 3 (TCA-3) are potent chemoattractants for Th2-polarized cells. Taken together, these observations strongly suggest that CCR8 plays a role in the control of Th2 responses, and may represent a potential target for treatment of allergic diseases.
在本文中,我们报告了小鼠CCR8的克隆及特性。与其人类同源物一样,它主要在胸腺中表达。在周边组织中,发现小鼠CCR8 mRNA在活化的Th2极化细胞和NK1.1 + CD4 + T细胞中表达最为丰富。人类CCR8也优先在人类Th2极化细胞和克隆中表达。这种表达模式表明CCR8是Th2特异性基因表达程序的一部分。CCR8配体I-309及其小鼠同源物T细胞活化基因3(TCA-3)是Th2极化细胞的有效趋化剂。综上所述,这些观察结果强烈表明CCR8在Th2反应的控制中发挥作用,并且可能代表治疗过敏性疾病的潜在靶点。